Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Major Shareholding Notification 2022

Jun 2, 2022

61842_rns_2022-06-02_70b080a4-ed2b-4535-a967-0b82d0e92e1e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [518 x 78] intentionally omitted <==

01 June,2022

To

BSE Limited
Phiroze Jeejeebhoy
Towers, Dalal Street,
Mumbai - 400 001
National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (E), Mumbai - 400
051
Scrip code: 541540 Scrip code: SOLARA

S. Murali Krishna

Company Secretary & Compliance Officer Solara Active Pharma Sciences Limited 2nd Floor, Admin Block, 27, Vandaloor, Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO Chennai - 600127

Dear Sir/ Madam,

Sub: Disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited

Pursuant to Regulation 10(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (‘SEBI SAST Regulations’), kindly find enclosed herewith disclosure in the prescribed format with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited, through an off-market transaction.

Kindly take the same on record.

Thanking you,

Yours faithfully,

JYOTHINAGARAVY Digitally signed by ASHA SRIRAMAN JYOTHINAGARAVYASHA SRIRAMAN RAMAPRASAD RAMAPRASAD Date: 2022.06.01 18:40:08 +05'30'

==> picture [76 x 77] intentionally omitted <==

Jyothinagaravyasha Sriraman Ramaprasad Designated Partner Devicam Capital LLP

Encl.: A/a

==> picture [518 x 78] intentionally omitted <==

- Disclosures under Regulation 10(5) Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeover Regulations, 2011

1. Name of the Target Company (TC) Name of the Target Company (TC) Solara Active Pharma Sciences Limited
2. Name of the acquirer(s) Devicam Capital LLP
3. Whether the acquirer(s) is/ are
promoters of the TC prior to the
transaction. If not, nature of
relationship or association with
the TC or its promoters
Yes, The Acquirer forms part of the Promoter group.
4. Details of theproposed acquisition
a. Name of the person(s) from
whom shares are to be
acquired
Mr. Arun Kumar Pillai
b. Proposed date of acquisition 08June,2022 or thereafter
c. Number of shares to be
acquired from each person
mentioned in 4(a)above
15,00,000 shares
d. Total shares to be acquired as
% of share capital of the TC
share
capital of TC
4.17%
e. Price at which shares are
proposed to be
Acquired
Rs. 408.90/- (Rupees Four Hundred and Eight Decimal
Ninety Paise only) per share aggregating to Rs.
61,33,50,000/- (Rupees Sixty-One Crores Thirty-Three
LakhsFiftyThousand Only)
f. Rationale, if any, for the
proposed transfer
Inter-se transfer of shares amongst Promoter and Promoter
group
5. Relevant sub-clause of regulation
10(1)(a) under
which the acquirer is exempted
from makingopen offer
10(1)(a)(i) of SEBI SAST Regulations
6. If,
frequently traded, volume
weighted average market price
for a period of 60 trading
days
preceding the date of
issuance of this notice as traded
on the stock exchange where the
maximum volume of trading in
the shares of the
TC
are
recorded during such
period.
Applicable
Volume Weighted Average Market Price: Rs. 627.89/-
(Rupees Six Hundred and Twenty-Seven Decimal Eighty-Nine
Paise Only)
7. If in-frequently traded, the price
as determined in terms of clause
(e) of sub-regulation (2) of
regulation 8.
Not Applicable
8. Declaration by the acquirer, that
the acquisition price would not be
higher by more than 25% of the
price computed in point 6 or
point 7 as applicable.
Applicable- Declaration Attached

==> picture [518 x 78] intentionally omitted <==

9. Declaration by the acquirer, that
the transferor and transferee
have complied / will comply with
applicable
disclosure
requirements in Chapter V of the
Takeover Regulations, 2011
(corresponding provisions of the
repealed Takeover Regulations
1997)


Applicable- Declaration Attached


Applicable- Declaration Attached


Applicable- Declaration Attached


Applicable- Declaration Attached
10. Declaration by the acquirer that
all the conditions specified under
regulation 10(1)(a) with respect
to exemptions has been
duly complied with
Applicable- Declaration Attached
11. Shareholding details Before the proposed
transaction
After the proposed
transaction
No. of
shares/votin
g rights
% wrt to
total share
capital of
TC
No. of
shares/votin
g rights
% wrt to
total share
capital of TC
A Acquirer(s) and PACs (other
than sellers)(*)

than
(i) Devicam Capital LLP 15,15,46 0.42 16,51,546 4.59
B Seller (s)
(i) Mr. Arun Kumar Pillai 31,68,463 8.80 16,68,463 4.63
() Shareholding of each entity may be shown separately and then collectively in a group. The above
disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one
acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so
on behalf of all the acquirers.
Signature:

Jyothinagaravyasha Sriraman Ramaprasad
Designated Partner
Devicam Capital LLP*
Date: 01 June,2022
Place: Bengaluru
JYOTHINAGARAVY
ASHA SRIRAMAN
RAMAPRASAD
Digitally signed by
JYOTHINAGARAVYASHA
SRIRAMAN RAMAPRASAD
Date: 2022.06.01 18:40:27
+05'30'

==> picture [518 x 78] intentionally omitted <==

DECLARATION

01 June,2022

We, Devicam Capital LLP (‘’The LLP’’) hereby declare that the acquisition price Rs. 408.90/- (Rupees Four Hundred and Eight Decimal Ninety Paise only) for acquiring 15,00,000 (Fifteen Lakhs) equity shares (through Inter-se Transfer of Shares) of Solara Active Pharma Sciences Limited (‘’Target Company’’) by the LLP is not higher than:

“Frequently traded volume weighted average market price for a period of 60 days preceding the date of issuance of notice as traded on the stock exchange where minimum volume of trading in the shares of the TC (Target Company) are recorded during such period. - (Point 6 of the Disclosure under Regulation 10 (5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.)’’

==> picture [76 x 77] intentionally omitted <==

For Devicam Capital LLP

JYOTHINAGARAVY Digitally signed by JYOTHINAGARAVYASHA ASHA SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.01 18:40:39 RAMAPRASAD +05'30'

Jyothinagaravyasha Sriraman Ramaprasad Designated Partner DPIN: 00173696

==> picture [518 x 78] intentionally omitted <==

DECLARATION

01 June,2022

We, Devicam Capital LLP (‘’The LLP’’) hereby declare that:

  1. The Transferor (Mr. Arun Kumar Pillai) and Transferee (Devicam Capital LLP) have complied/ will comply with applicable disclosure requirements in Chapter V of the Takeover Regulations, 2011 (corresponding provisions of repealed Takeover Regulations 1997.)

  2. Devicam Capital LLP (The Acquirer) has complied with all the conditions specified under Regulation 10(1)(a) with respect to exemptions has been duly complied with.

For Devicam Capital LLP

JYOTHINAGARAV Digitally signed by JYOTHINAGARAVYASHA YASHA SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.01 18:40:49 RAMAPRASAD +05'30'

==> picture [76 x 76] intentionally omitted <==

Jyothinagaravyasha Sriraman Ramaprasad Designated Partner DPIN: 00173696